EUVIMEDEUVIMED entdecken
Open Access

Hepatocyte-specific deletion of small heterodimer partner protects mice against acetaminophen-induced hepatotoxicity via activation of Nrf2

Priyanka Ghosh, Nancy Magee, Jephte Y Akakpo, Forkan Ahamed iD, Natalie Eppler, Elizabeth Jones, Yifan Yu, Lily He, Margitta Lebofsky, Hongyan Dai, Hartmut Jaeschke iD, Wen-Xing Ding und 1 weitere

Toxicological Sciences · 01.01.2024 · 197 (1) · 53-68

DOI: 10.1093/toxsci/kfad104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 04.10.2023. Verfasst von Priyanka Ghosh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160, USA. Hauptthemen laut MEDLINE: Acetaminophen, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (APAP) overdose stands as the primary cause of acute liver failure in the United States. APAP hepatotoxicity involves hepatic glutathione (GSH) depletion and mitochondrial damage. To counteract the toxicity of APAP, the nuclear factor erythroid 2 like 2 (Nrf2) activates the expression of genes responsible for drug detoxification and GSH synthesis. In this study, we present evidence that the elimination of hepatocyte small heterodimer partner, a critical transcriptional repressor for liver metabolism, results in Nrf2 activation and protects mice from APAP-induced acute liver injury. Initial investigations conducted on wildtype (WT) mice revealed a swift downregulation of Shp mRNA within the first 24 h after APAP administration. Subsequent treatment of hepatocyte-specific Shp knockout (ShpHep−/−) mice with 300 mg/kg APAP for 2 h exhibited comparable bioactivation of APAP with that observed in the WT controls. However, a significant reduction in liver injury was observed in ShpHep−/− after APAP treatment for 6 and 24 h. The decreased liver injury correlated with a faster recovery of GSH, attributable to heightened expression of Nrf2 target genes involved in APAP detoxification and GSH synthesis. Moreover, in vitro studies revealed that SHP protein interacted with NRF2 protein, inhibiting the transcription of Nrf2 target genes. These findings hold relevance for humans, as overexpression of SHP hindered APAP-induced NRF2 activation in primary human hepatocytes. In conclusion, our studies have unveiled a novel regulatory axis involving SHP and NRF2 in APAP-induced acute liver injury, emphasizing SHP as a promising therapeutic target in APAP overdose-induced hepatotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenChemical and Drug Induced Liver InjuryHumansAnimalsMiceNF-E2-Related Factor 2Reactive Oxygen SpeciesHepatocytesLiverGlutathioneMice, Inbred C57BL

Stichwörter der Autor:innen

Nrf2acetaminophen hepatotoxicitygene knockoutnuclear receptorsmall heterodimer partner (SHP)transcription

Substanzen

AcetaminophenNF-E2-Related Factor 2Reactive Oxygen SpeciesGlutathione

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
  • Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.

ORCID-Profile: Forkan Ahamed, Hartmut Jaeschke, Yuxia Zhang

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • NCRR NIH HHS
  • NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • University of Kansas Clinical and Translational Science Institute

Zitieren

APA

Ghosh, P., Magee, N., Akakpo, J. Y., Ahamed, F., Eppler, N., Jones, E., Yu, Y., He, L., Lebofsky, M., Dai, H., Jaeschke, H., Ding, W. X., & Zhang, Y. (2024). Hepatocyte-specific deletion of small heterodimer partner protects mice against acetaminophen-induced hepatotoxicity via activation of Nrf2. Toxicological Sciences, 197(1), 53-68. https://doi.org/10.1093/toxsci/kfad104

Vancouver

Ghosh P, Magee N, Akakpo JY, Ahamed F, Eppler N, Jones E, et al. Hepatocyte-specific deletion of small heterodimer partner protects mice against acetaminophen-induced hepatotoxicity via activation of Nrf2. Toxicological Sciences. 2024;197(1):53-68. doi:10.1093/toxsci/kfad104

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Priyanka and Magee, Nancy and Akakpo, Jephte Y and Ahamed, Forkan and Eppler, Natalie and Jones, Elizabeth and Yu, Yifan and He, Lily and Lebofsky, Margitta and Dai, Hongyan and Jaeschke, Hartmut and Ding, Wen-Xing and Zhang, Yuxia},
  title = {Hepatocyte-specific deletion of small heterodimer partner protects mice against acetaminophen-induced hepatotoxicity via activation of Nrf2},
  journal = {Toxicological Sciences},
  year = {2024},
  volume = {197},
  number = {1},
  pages = {53--68},
  doi = {10.1093/toxsci/kfad104}
}
Kostenlos starten →